{"id":1886,"date":"2021-08-13T10:52:00","date_gmt":"2021-08-13T08:52:00","guid":{"rendered":"https:\/\/afpca.fr\/site\/?p=1886"},"modified":"2023-11-23T11:13:15","modified_gmt":"2023-11-23T10:13:15","slug":"mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires","status":"publish","type":"post","link":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/","title":{"rendered":"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1886\" class=\"elementor elementor-1886\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-15a67f3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"15a67f3\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8cae62b\" data-id=\"8cae62b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0721df3 elementor-widget elementor-widget-text-editor\" data-id=\"0721df3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Pour information, nous venons de publier une mise \u00e0 jour de la fiche de recommandations pour les patients adultes atteints de maladies auto-immunes ou auto-inflammatoires en p\u00e9riode \u00e9pid\u00e9mique COVID-19, tenant compte des derni\u00e8res recommandations du Conseil d&#8217;Orientation de la Strat\u00e9gie Vaccinale (COSV).<\/p><p>Vous pouvez \u00a0<a href=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2022\/04\/VF_COVID19_Recos_patients_FAI2R.pdf\">t\u00e9l\u00e9charger la fiche PDF en cliquant ici<\/a>.<\/p><p>Si je suis fortement immunod\u00e9prim\u00e9 et n\u2019ai pas fait d\u2019anticorps apr\u00e8s un sch\u00e9ma vaccinal complet ou si je suis non \u00e9ligible \u00e0 la vaccination (*Plus d\u2019infos : <a href=\"https:\/\/urlz.fr\/gYzQ\">ici<\/a> et sur <a href=\"https:\/\/urlz.fr\/gYzP\">Ameli<\/a>)<\/p><p>la combinaison tixagevimab\/cilgavimab peut aussi \u00eatre propos\u00e9e en pr\u00e9vention de la COVID-19 avec une administration d\u2019une dose unique apportant une protection pendant au moins 6 mois dans les cas suivants : patients insuffisamment ou non r\u00e9pondeurs apr\u00e8s un sch\u00e9ma vaccinal complet et \u00e0 risque de forme s\u00e9v\u00e8re de COVID-19 ou non \u00e9ligible \u00e0 la vaccination et qui sont \u00e0 haut risque de forme s\u00e9v\u00e8re de COVID-19* (tels que patients recevant un traitement par rituximab, azathioprine, cyclophosphamide ou mycoph\u00e9nolate mof\u00e9til, patients ayant re\u00e7u une greffe d\u2019organe solide&#8230;).\u00a0 Dans ces situations, contactez le m\u00e9decin hospitalier r\u00e9f\u00e9rent de votre maladie qui pourra vous conseiller, vous orienter si besoin et juger si un traitement sp\u00e9cifique ou une hospitalisation est n\u00e9cessaire.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Pour information, nous venons de publier une mise \u00e0 jour de la fiche de recommandations pour les patients adultes atteints de maladies auto-immunes ou auto-inflammatoires en p\u00e9riode \u00e9pid\u00e9mique COVID-19, tenant compte des derni\u00e8res recommandations du Conseil d&#8217;Orientation de la Strat\u00e9gie Vaccinale (COSV). Vous pouvez \u00a0t\u00e9l\u00e9charger la fiche PDF en cliquant ici. Si je suis fortement [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":24,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-1886","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","6":"hentry","7":"category-non-classe","9":"post-with-thumbnail","10":"post-with-thumbnail-large"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires - Association Francophone Contre La Polychondrite Chronique Atrophiante<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires - Association Francophone Contre La Polychondrite Chronique Atrophiante\" \/>\n<meta property=\"og:description\" content=\"Pour information, nous venons de publier une mise \u00e0 jour de la fiche de recommandations pour les patients adultes atteints de maladies auto-immunes ou auto-inflammatoires en p\u00e9riode \u00e9pid\u00e9mique COVID-19, tenant compte des derni\u00e8res recommandations du Conseil d&#8217;Orientation de la Strat\u00e9gie Vaccinale (COSV). Vous pouvez \u00a0t\u00e9l\u00e9charger la fiche PDF en cliquant ici. Si je suis fortement [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/\" \/>\n<meta property=\"og:site_name\" content=\"Association Francophone Contre La Polychondrite Chronique Atrophiante\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/42710644010\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-13T08:52:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-23T10:13:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2021\/03\/logo_fai2r.png\" \/>\n\t<meta property=\"og:image:width\" content=\"165\" \/>\n\t<meta property=\"og:image:height\" content=\"117\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"webmaster_afpca\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster_afpca\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/\"},\"author\":{\"name\":\"webmaster_afpca\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/person\\\/51c98554e1e9914c58daecf2d0e9822e\"},\"headline\":\"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires\",\"datePublished\":\"2021-08-13T08:52:00+00:00\",\"dateModified\":\"2023-11-23T10:13:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/\"},\"wordCount\":241,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo_fai2r.png\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/\",\"name\":\"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires - Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo_fai2r.png\",\"datePublished\":\"2021-08-13T08:52:00+00:00\",\"dateModified\":\"2023-11-23T10:13:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#primaryimage\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo_fai2r.png\",\"contentUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo_fai2r.png\",\"width\":165,\"height\":117,\"caption\":\"fai2r\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\",\"name\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"description\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"publisher\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/afpca.fr\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\",\"name\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/LOGO_afpca.png\",\"contentUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/LOGO_afpca.png\",\"width\":184,\"height\":184,\"caption\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/42710644010\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/person\\\/51c98554e1e9914c58daecf2d0e9822e\",\"name\":\"webmaster_afpca\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g\",\"caption\":\"webmaster_afpca\"},\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/author\\\/webmaster_afpca\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires - Association Francophone Contre La Polychondrite Chronique Atrophiante","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/","og_locale":"fr_FR","og_type":"article","og_title":"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires - Association Francophone Contre La Polychondrite Chronique Atrophiante","og_description":"Pour information, nous venons de publier une mise \u00e0 jour de la fiche de recommandations pour les patients adultes atteints de maladies auto-immunes ou auto-inflammatoires en p\u00e9riode \u00e9pid\u00e9mique COVID-19, tenant compte des derni\u00e8res recommandations du Conseil d&#8217;Orientation de la Strat\u00e9gie Vaccinale (COSV). Vous pouvez \u00a0t\u00e9l\u00e9charger la fiche PDF en cliquant ici. Si je suis fortement [&hellip;]","og_url":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/","og_site_name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","article_publisher":"https:\/\/www.facebook.com\/groups\/42710644010","article_published_time":"2021-08-13T08:52:00+00:00","article_modified_time":"2023-11-23T10:13:15+00:00","og_image":[{"width":165,"height":117,"url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2021\/03\/logo_fai2r.png","type":"image\/png"}],"author":"webmaster_afpca","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"webmaster_afpca","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#article","isPartOf":{"@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/"},"author":{"name":"webmaster_afpca","@id":"https:\/\/afpca.fr\/site\/#\/schema\/person\/51c98554e1e9914c58daecf2d0e9822e"},"headline":"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires","datePublished":"2021-08-13T08:52:00+00:00","dateModified":"2023-11-23T10:13:15+00:00","mainEntityOfPage":{"@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/"},"wordCount":241,"commentCount":0,"publisher":{"@id":"https:\/\/afpca.fr\/site\/#organization"},"image":{"@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#primaryimage"},"thumbnailUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2021\/03\/logo_fai2r.png","inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/","url":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/","name":"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires - Association Francophone Contre La Polychondrite Chronique Atrophiante","isPartOf":{"@id":"https:\/\/afpca.fr\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#primaryimage"},"image":{"@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#primaryimage"},"thumbnailUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2021\/03\/logo_fai2r.png","datePublished":"2021-08-13T08:52:00+00:00","dateModified":"2023-11-23T10:13:15+00:00","breadcrumb":{"@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#primaryimage","url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2021\/03\/logo_fai2r.png","contentUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2021\/03\/logo_fai2r.png","width":165,"height":117,"caption":"fai2r"},{"@type":"BreadcrumbList","@id":"https:\/\/afpca.fr\/site\/mise-a-jour-de-la-fiche-de-recommandations-covid-19-pour-les-patients-atteints-de-maladies-auto-immunes-ou-auto-inflammatoires\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/afpca.fr\/site\/"},{"@type":"ListItem","position":2,"name":"Avril 2022 : mise \u00e0 jour de la fiche de recommandations COVID-19 pour les patients atteints de maladies auto-immunes ou auto-inflammatoires"}]},{"@type":"WebSite","@id":"https:\/\/afpca.fr\/site\/#website","url":"https:\/\/afpca.fr\/site\/","name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","description":"Association Francophone Contre La Polychondrite Chronique Atrophiante","publisher":{"@id":"https:\/\/afpca.fr\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/afpca.fr\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/afpca.fr\/site\/#organization","name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","url":"https:\/\/afpca.fr\/site\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/afpca.fr\/site\/#\/schema\/logo\/image\/","url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2023\/05\/LOGO_afpca.png","contentUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2023\/05\/LOGO_afpca.png","width":184,"height":184,"caption":"Association Francophone Contre La Polychondrite Chronique Atrophiante"},"image":{"@id":"https:\/\/afpca.fr\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/42710644010"]},{"@type":"Person","@id":"https:\/\/afpca.fr\/site\/#\/schema\/person\/51c98554e1e9914c58daecf2d0e9822e","name":"webmaster_afpca","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8ceed7420502a29ef58778714f74aee5826a58566284b1b505f52207bb7285a5?s=96&d=mm&r=g","caption":"webmaster_afpca"},"url":"https:\/\/afpca.fr\/site\/author\/webmaster_afpca\/"}]}},"_links":{"self":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts\/1886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/comments?post=1886"}],"version-history":[{"count":0,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/posts\/1886\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/media\/24"}],"wp:attachment":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/media?parent=1886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/categories?post=1886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/tags?post=1886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}